Article Sidebar

PDF
Date Published: 16/06/2024
Abstract Views: 99
Views PDF: 29
DOI: https://doi.org/10.51298/vmj.v539i3.10067
Issue
Vol. 539 No. 3 (2024)
Section
Các bài báo
How to Cite
Phạm, T. A., & Trịnh , H. P. (2024). SOME CHARACTERISTICS OF TUMOR MARKERS IN PATIENTS UNDERWENT LIVER RESECTION FOR ICC AT K HOSPITAL. Vietnam Medical Journal, 539(3). https://doi.org/10.51298/vmj.v539i3.10067

SOME CHARACTERISTICS OF TUMOR MARKERS IN PATIENTS UNDERWENT LIVER RESECTION FOR ICC AT K HOSPITAL

Thế Anh Phạm1,, Huy Phương Trịnh 1
1 Vietnam National Cancer Hospital

Main Article Content

Abstract

Objective: Describe some characteristics of tumor markers in patients undergoing liver resection for Intrahepatic cholangiocarcinoma (ICC) at K Hospital. Subjects and methods: Retrospective descriptive study on 33 patients undergoing surgery. Surgical hepatectomy with hepatic pedicle lymphadenectomy due to ICC at the Department of Hepatobiliary Pancreatic Surgery - K Hospital from October 2021 to December 2023. Results: Male: female ratio: 0.8:1; Average age: 58.8 ± 11.1; Types of hepatectomy include: 14 right hepatectomy cases and 19 left hepatectomy cases; CA 19-9, AFP, CEA increased in 57.6%, 12.1% and 9.1% of cases, respectively; On CT scanner, 93.9% of patients had one tumor, 33.3% of patients had tumors > 5cm. The rate of increased CA 19-9 (24.3%) was 2.7 times higher than the normal CA 19-9 group (9.1%) in the group of patients with tumor size > 5cm and the group of patients with vascular invasion, with p value was both 0.278. Lymph node metastasis in patients with increased CA 19-9 (30.3%) was higher than in the group with normal CA 19-9 (15.2%), with p value was 0.335. Conclusion: CA 19-9, AFP, CEA increased in 57.6%, 12.1% and 9.1% of cases, respectively. CA 19-9 was increased in the group of patients with tumor size > 5cm, tumor infiltration, and lymph node metastasis, but the differences were not statistically significant with p > 0.05.

Article Details

Keywords

.05. Keywords: Tumor marker, Intrahepatic cholangiocarcinoma, Hepatectomy

References

1. Banales, J.M., et al., Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nature reviews Gastroenterology & hepatology, 2020. 17(9): p. 557-588.
2. Moris, D., et al., Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians. 2023. 73(2): p. 198-222.
3. Malaguarnera G, P.I., Giordano M, et al., Serum markers of intrahepatic cholangiocarcinoma.
4. Jaklitsch, M., The power to predict with biomarkers: carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA) serum markers in intrahepatic cholangiocarcinoma.
5. Moro, A., The Impact of Preoperative CA 19-9 and CEA on Outcomes of Patients with Intrahepatic Cholangiocarcinoma.
6. Harrison, L., et al., Surgical treatment of 32 patients with peripheral intrahepatic cholangiocarcinoma. British journal of surgery, 1998. 85(8): p. 1068-1070.
7. Addeo, P., et al., Prognostic impact of tumor multinodularity in intrahepatic cholangiocarcinoma. 2019. 23: p. 1801-1809.
8. Đồng Đức Hoàng, Mối liên quan giữa nồng độ CA 19-9, CEA huyết thanh với một số yếu tố ở bệnh nhân ung thư đường mật.
9. Xijuan Ma, L.L., MRI features predict microvascular invasion in intrahepatic cholangiocarcinoma.
10. Yamada, T., Nakanishi, Y., Okamura, K., Impact of serum CA 19-9 level on prognosis and prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma.